A Multicenter Randomized Double Blind Placebo Controlled Study to Evaluate the Efficacy and Safety of Alogliptin Compared with Placebo in Pediatric Subjects with Type 2 Diabetes Mellitus

  • Thrailkill, Kathryn (PI)

Grants and Contracts Details

StatusFinished
Effective start/end date7/3/186/26/20